Physician profile
Daniel D Nale
NPI 1225128028
$374.79
in general payments reported to CMS, 2019-2025
7 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.55 · 2020: $51.51 · 2021: $51.67 · 2022: $31.88 · 2023: $17.10 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $133.47 | 2019-2022 | |
| Sanofi Pasteur INC. | $120.19 | 2025 | |
| Cranial Technologies, INC | $40.64 | 2021-2025 | Doc Band |
| Glaxosmithkline, LLC. | $26.64 | 2019-2020 | |
| Kaleo, INC. | $21.58 | 2020 | |
| Merck Sharp & Dohme LLC | $17.10 | 2023 | M-M-R II, Vaxelis, Gardasil 9 |
| Neos Therapeutics, Lp | $15.17 | 2025 | Cotempla Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Nale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.